These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9439582

  • 21. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
    Daff SN, Chapman SK, Turner KL, Holt RA, Govindaraj S, Poulos TL, Munro AW.
    Biochemistry; 1997 Nov 11; 36(45):13816-23. PubMed ID: 9374858
    [Abstract] [Full Text] [Related]

  • 22. P450BM-3: reduction by NADPH and sodium dithionite.
    Peterson JA, Boddupalli SS.
    Arch Biochem Biophys; 1992 May 01; 294(2):654-61. PubMed ID: 1567220
    [Abstract] [Full Text] [Related]

  • 23. Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions.
    Boddupalli SS, Pramanik BC, Slaughter CA, Estabrook RW, Peterson JA.
    Arch Biochem Biophys; 1992 Jan 01; 292(1):20-8. PubMed ID: 1727637
    [Abstract] [Full Text] [Related]

  • 24. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK, Arnold FH, Gray HB.
    J Inorg Biochem; 2004 Sep 01; 98(9):1547-50. PubMed ID: 15337607
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cytochrome P450BM-3 (CYP102): regiospecificity of oxidation of omega-unsaturated fatty acids and mechanism-based inactivation.
    Shirane N, Sui Z, Peterson JA, Ortiz de Montellano PR.
    Biochemistry; 1993 Dec 14; 32(49):13732-41. PubMed ID: 8257708
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB, Schmid RD.
    Methods Enzymol; 2004 Dec 14; 388():208-24. PubMed ID: 15289074
    [No Abstract] [Full Text] [Related]

  • 29. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
    Haines DC, Chen B, Tomchick DR, Bondlela M, Hegde A, Machius M, Peterson JA.
    Biochemistry; 2008 Mar 25; 47(12):3662-70. PubMed ID: 18298086
    [Abstract] [Full Text] [Related]

  • 30. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
    Chen HC, Swenson RP.
    Biochemistry; 2008 Dec 30; 47(52):13788-99. PubMed ID: 19055322
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3.
    Klein ML, Fulco AJ.
    J Biol Chem; 1993 Apr 05; 268(10):7553-61. PubMed ID: 8463285
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH, Kim KH, Kim DH, Jung HC, Pan JG.
    Trends Biotechnol; 2007 Jul 05; 25(7):289-98. PubMed ID: 17532492
    [Abstract] [Full Text] [Related]

  • 37. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA, Roman LJ, Miller RT, Masters BS.
    Arch Biochem Biophys; 2001 Jan 15; 385(2):311-21. PubMed ID: 11368012
    [Abstract] [Full Text] [Related]

  • 38. Chimeragenesis of the fatty acid binding site of cytochrome P450BM3. Replacement of residues 73-84 with the homologous residues from the insect cytochrome P450 CYP4C7.
    Murataliev MB, Trinh LN, Moser LV, Bates RB, Feyereisen R, Walker FA.
    Biochemistry; 2004 Feb 24; 43(7):1771-80. PubMed ID: 14967018
    [Abstract] [Full Text] [Related]

  • 39. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
    Dietrich M, Do TA, Schmid RD, Pleiss J, Urlacher VB.
    J Biotechnol; 2009 Jan 01; 139(1):115-7. PubMed ID: 18984016
    [Abstract] [Full Text] [Related]

  • 40. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW, Meinhold P, Glieder A, Arnold FH.
    J Am Chem Soc; 2003 Nov 05; 125(44):13442-50. PubMed ID: 14583039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.